Zobrazeno 1 - 10
of 337
pro vyhledávání: '"Klieber S"'
Autor:
Pouzin C; Sanofi R&D, Pharmacokinetics Dynamics and Metabolism Department, Paris, France., Teutonico D; Sanofi R&D, Pharmacokinetics Dynamics and Metabolism Department, Paris, France., Fagniez N; Sanofi R&D, Pharmacokinetics Dynamics and Metabolism Department, Paris, France., Ziti-Ljajic S; Sanofi R&D, Pharmacokinetics Dynamics and Metabolism Department, Paris, France., Perreard-Dumaine A; Sanofi R&D, Biomarkers and Clinical Bioanalysis, Paris, France., Pardon M; Sanofi R&D, CMC Early Development, Paris, France., Klieber S; Sanofi R&D, In vitro ADME, Drug Metabolism and Pharmacokinetics, Paris, France., Nguyen L; Sanofi R&D, Pharmacokinetics Dynamics and Metabolism Department, Paris, France.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Feb; Vol. 115 (2), pp. 278-287. Date of Electronic Publication: 2023 Dec 03.
Autor:
Jain T; Department of Computational Biology, Adimab LLC, Mountain View, CA, USA., Prinz B; Department of Antibody Discovery, Adimab LLC, Lebanon, NH, USA., Marker A; Department of Drug Metabolism and Pharmacokinetics, Sanofi, Frankfurt, Germany., Michel A; Department of Drug Metabolism and Pharmacokinetics, Sanofi, Cambridge, MA, USA., Reichel K; Department of Large Molecule Research, Sanofi, Frankfurt, Germany., Czepczor V; Department of Drug Metabolism and Pharmacokinetics, Sanofi, Paris, France., Klieber S; Department of Drug Metabolism and Pharmacokinetics, Sanofi, Paris, France., Sun W; Department of Drug Metabolism and Pharmacokinetics, Sanofi, Cambridge, MA, USA., Kathuria S; Department of Large Molecule Research, Sanofi, Cambridge, MA, USA., Oezguer Bruederle S; Department of Large Molecule Research, Sanofi, Frankfurt, Germany., Lange C; Department of Large Molecule Research, Sanofi, Frankfurt, Germany., Wahl L; Department of Large Molecule Research, Sanofi, Frankfurt, Germany., Starr C; Sanofi, Global CMC Development, Framingham, MA, USA., Masiero A; Department of Large Molecule Research, Sanofi, Paris, France., Avery L; Department of Drug Metabolism and Pharmacokinetics, Sanofi, Cambridge, MA, USA.
Publikováno v:
MAbs [MAbs] 2024 Jan-Dec; Vol. 16 (1), pp. 2384104. Date of Electronic Publication: 2024 Jul 31.
Autor:
Nicolas O; Department of Translational Medicine and Early Development, Sanofi, 371 Rue Professeur Blayac, 34184, Montpellier, France. Olivier.Nicolas@sanofi.com., Moliner P; Department of Translational Medicine and Early Development, Sanofi, 371 Rue Professeur Blayac, 34184, Montpellier, France., Soubayrol P; Department of Translational Medicine and Early Development, Sanofi, 371 Rue Professeur Blayac, 34184, Montpellier, France., Vitse O; Department of Translational Medicine and Early Development, Sanofi, 371 Rue Professeur Blayac, 34184, Montpellier, France., Roy S; Department of Integrated Drug Discovery/Isotope Chemistry, Sanofi, Paris, France., Cabanis MJ; Department of Translational Medicine and Early Development, Sanofi, 371 Rue Professeur Blayac, 34184, Montpellier, France., Turner T; MS Neurology Development, Sanofi, Cambridge, MA, USA., Klieber S; Department of Translational Medicine and Early Development, Sanofi, 371 Rue Professeur Blayac, 34184, Montpellier, France., Muccio S; Department of Translational Medicine and Early Development, Sanofi, 371 Rue Professeur Blayac, 34184, Montpellier, France., Arabeyre C; Department of Translational Medicine and Early Development, Sanofi, 371 Rue Professeur Blayac, 34184, Montpellier, France., Brun P; Department of Translational Medicine and Early Development, Sanofi, 371 Rue Professeur Blayac, 34184, Montpellier, France.
Publikováno v:
Clinical drug investigation [Clin Drug Investig] 2023 Aug; Vol. 43 (8), pp. 653-665. Date of Electronic Publication: 2023 Aug 29.
Autor:
Murithi JM; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Pascal C; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Bath J; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Boulenc X; Sanofi Pasteur, Marcy L'Etoile, France., Gnädig NF; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Pasaje CFA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Rubiano K; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Yeo T; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Mok S; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA., Klieber S; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France., Desert P; Sanofi Pasteur, Marcy L'Etoile, France., Jiménez-Díaz MB; The Art of Discovery, Bizkaia, Basque Country, Spain., Marfurt J; Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia., Rouillier M; Medicines for Malaria Venture, Geneva, Switzerland., Cherkaoui-Rbati MH; Medicines for Malaria Venture, Geneva, Switzerland., Gobeau N; Medicines for Malaria Venture, Geneva, Switzerland., Wittlin S; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland.; Universität Basel, Basel, Switzerland., Uhlemann AC; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Price RN; Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia.; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Wirjanata G; Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Australia., Noviyanti R; Eijkman Institute for Molecular Biology, Jakarta, Indonesia., Tumwebaze P; Infectious Diseases Research Collaboration, Kampala, Uganda., Cooper RA; Department of Natural Sciences and Mathematics, Dominican University of California, San Rafael, CA, USA., Rosenthal PJ; Department of Medicine, University of California, San Francisco, CA, USA., Sanz LM; Global Health Pharma Research Unit, GSK, Tres Cantos, Madrid, Spain., Gamo FJ; Global Health Pharma Research Unit, GSK, Tres Cantos, Madrid, Spain., Joseph J; Syngene International Ltd., Bangalore, India., Singh S; Syngene International Ltd., Bangalore, India., Bashyam S; Syngene International Ltd., Bangalore, India., Augereau JM; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Giraud E; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Bozec T; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Vermat T; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Tuffal G; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France., Guillon JM; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Menegotto J; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Sallé L; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France., Louit G; Sanofi, Vitry-sur-Seine, France., Cabanis MJ; Sanofi R&D, Translational Medicine & Early Development, Montpellier, France., Nicolas MF; Sanofi, Vitry-sur-Seine, France., Doubovetzky M; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Merino R; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Bessila N; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Angulo-Barturen I; The Art of Discovery, Bizkaia, Basque Country, Spain., Baud D; Medicines for Malaria Venture, Geneva, Switzerland., Bebrevska L; Medicines for Malaria Venture, Geneva, Switzerland., Escudié F; Medicines for Malaria Venture, Geneva, Switzerland., Niles JC; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, USA., Blasco B; Medicines for Malaria Venture, Geneva, Switzerland., Campbell S; Medicines for Malaria Venture, Geneva, Switzerland., Courtemanche G; Bioaster, Paris, France., Fraisse L; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Pellet A; Sanofi, Infectious Diseases Therapeutic Area, Marcy l'Etoile, France., Fidock DA; Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY, USA. df2260@cumc.columbia.edu leroyd@mmv.org.; Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA., Leroy D; Medicines for Malaria Venture, Geneva, Switzerland. df2260@cumc.columbia.edu leroyd@mmv.org.
Publikováno v:
Science translational medicine [Sci Transl Med] 2021 Jul 21; Vol. 13 (603).
Autor:
Da-Silva F; Sanofi R&D, Montpellier, France; Institute for Regenerative Medicine and Biotherapy, Université et CHU de Montpellier, INSERM, Montpellier, France., Boulenc X; Sanofi R&D, Montpellier, France., Vermet H; Sanofi R&D, Montpellier, France., Compigne P; Sanofi R&D, Montpellier, France., Gerbal-Chaloin S; Institute for Regenerative Medicine and Biotherapy, Université et CHU de Montpellier, INSERM, Montpellier, France., Daujat-Chavanieu M; Institute for Regenerative Medicine and Biotherapy, Université et CHU de Montpellier, INSERM, Montpellier, France., Klieber S; Sanofi R&D, Montpellier, France. Electronic address: sylvie.klieber@sanofi.com., Poulin P; Consultant, Patrick Poulin Inc., Québec City, Canada; Associate professor, School of Public Health, IRSPUM, Université de Montréal, Canada.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2018 Jul; Vol. 107 (7), pp. 1957-1972. Date of Electronic Publication: 2018 Mar 07.
Autor:
Yin, Xuefen1 (AUTHOR) xuefenyin@ufl.edu, Cicali, Brian1 (AUTHOR) bcicali@ufl.edu, Rodriguez-Vera, Leyanis1 (AUTHOR) leyanisrv80@gmail.com, Lukacova, Viera2 (AUTHOR) viera.lukacova@simulations-plus.com, Cristofoletti, Rodrigo1 (AUTHOR) rcristofoletti@ufl.edu, Schmidt, Stephan1 (AUTHOR) rcristofoletti@ufl.edu
Publikováno v:
Pharmaceutics. Jun2024, Vol. 16 Issue 6, p737. 25p.
Autor:
Peter, Jens-Uwe1 (AUTHOR) jens-uwe.peter@mhb-fontane.de, Dieudonné, Peter2 (AUTHOR), Zolk, Oliver1 (AUTHOR) oliver.zolk@mhb-fontane.de
Publikováno v:
Pharmaceuticals (14248247). Apr2024, Vol. 17 Issue 4, p473. 21p.
Autor:
Frybortova, Veronika1 (AUTHOR) veronika.frybortova@upol.cz, Satka, Stefan1 (AUTHOR) eva.anzenbacherova@upol.cz, Jourova, Lenka1 (AUTHOR), Zapletalova, Iveta2 (AUTHOR) iveta.zapletalova@upol.cz, Srejber, Martin3 (AUTHOR), Briolotti, Philippe4 (AUTHOR) sabine.gerbal-chaloin@inserm.fr, Daujat-Chavanieu, Martine4 (AUTHOR), Gerbal-Chaloin, Sabine4 (AUTHOR), Anzenbacher, Pavel2 (AUTHOR) pavel.anzenbacher@upol.cz, Otyepka, Michal3,5 (AUTHOR), Anzenbacherova, Eva1 (AUTHOR)
Publikováno v:
International Journal of Molecular Sciences. Apr2024, Vol. 25 Issue 7, p3610. 16p.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.